Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
77,533,333
-
Total 13F shares
-
37,594,933
-
Share change
-
+2,594,716
-
Total reported value
-
$213,228,886
-
Put/Call ratio
-
537%
-
Price per share
-
$5.67
-
Number of holders
-
78
-
Value change
-
+$13,669,240
-
Number of buys
-
53
-
Number of sells
-
21
Institutional Holders of Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB) as of Q2 2024
As of 30 Jun 2024,
Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,594,933 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Bain Capital Life Sciences Investors, LLC, Vestal Point Capital, LP, Artal Group S.A., ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MILLENNIUM MANAGEMENT LLC, BlackRock Inc., and ADAR1 Capital Management, LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.